Related Experiment Video
Updated: Jun 10, 2026

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy
Jee-Young Lee1, Ji Young Yun, Chae-Won Shin
1Department of Neurology, Seoul National University Boramae Hospital, Seoul, Korea.
Abstract:
To evaluate the diagnostic value of putaminal abnormality on 3-T magnetic resonance imaging (MRI) for differentiating early parkinsonism-predominant multiple system atrophy (MSA-p) from Parkinson disease (PD) based on long-term clinical follow-up data. Totals of 23 clinical MSA-p (6 possible and 17 suspicious) and 50 PD patients were included. Subjects submitted to 3-T MRI at baseline and were followed up to substantiate the initial diagnosis. MRI findings were compared between MSA-p and PD patients based on the final diagnosis. Putaminal abnormalities were recorded as presence of atrophy, signal hypointensity, and abnormal disruption of the hyperintense lateral rim of the putamen. The sum scores for putaminal abnormality were calculated from the presence of each item. During the follow-up over 3 years, the diagnosis of MSA-p was supported in 17 patients (14 probable and 3 possible) and the diagnosis of PD was stable in all 50 patients. Putaminal abnormalities were more frequent in MSA-p (n = 17) than in PD (n = 50). A sum score of >1 on 3-T MRI had sensitivity, specificity, and positive- and negative-predictive values of 70.6, 93, 77.4, and 90.3%, respectively, for differentiating MSA-p from PD. Fourteen of the initial 23 clinical MSA-p patients had a sum score of >1, and in all but two, the diagnosis became supported during the follow-up, whereas the diagnosis of five of the nine patients with a sum score of ≤1 remained uncertain. Putaminal abnormality on 3-T MRI can be a specific diagnostic marker for early stage MSA-p.
Insights
Putaminal abnormalities on 3-T MRI can help distinguish early parkinsonism-predominant multiple system atrophy (MSA-p) from Parkinson disease (PD). A specific MRI scoring system shows high accuracy in differentiating these conditions.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Differentiating early parkinsonism-predominant multiple system atrophy (MSA-p) from Parkinson disease (PD) is clinically challenging.
- Accurate early diagnosis is crucial for appropriate patient management and treatment.
Purpose of the Study:
- To assess the diagnostic utility of 3-Tesla (3T) MRI-detected putaminal abnormalities for distinguishing MSA-p from PD.
- To correlate MRI findings with long-term clinical follow-up data.
Main Methods:
- A cohort of 23 clinically diagnosed MSA-p and 50 PD patients underwent 3T MRI at baseline.
- Putaminal abnormalities (atrophy, hypointensity, rim disruption) were assessed and scored.
- Patients were followed clinically for up to 3 years to confirm diagnoses.
Main Results:
- Putaminal abnormalities were significantly more frequent in MSA-p patients (17/17 confirmed) compared to PD patients (0/50).
- A sum score >1 on 3T MRI demonstrated high specificity (93%) and good sensitivity (70.6%) for identifying MSA-p.
- Patients with a sum score >1 were more likely to have their MSA-p diagnosis confirmed during follow-up.
Conclusions:
- Putaminal abnormality on 3T MRI serves as a specific imaging biomarker for early-stage MSA-p.
- 3T MRI findings, particularly putaminal changes, can aid in differentiating MSA-p from PD, improving diagnostic accuracy.
Related Concept Videos
Alterations in Muscle Tone lll
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
